SibMed became one of the organizers of the online conference "Genetic Technologies in Immunotherapy"
The conference is the first event as part of the Genetic Research for New Oncology consortium that is implementing the project "Genetic and epigenetic editing of tumor cells and microenvironment to block metastasis." The conference will be held at TSU along with the members of the consortium – Siberian State Medical University, Tomsk NRMC and BSMU.
The aim of the project is to identify the key genetic and epigenetic mechanisms that control metastasis.
Leading scientists in the field of oncology, immunology and genetic technologies will give speeches at the conference.
- Evgeny Imyanitov – Corresponding Member of the Russian Academy of Sciences, Doctor of Medical Sciences, Professor, Leading Molecular Oncologist and Oncogeneticist of Russia;
- Yulia Kzhyshkovska – Project Manager, Doctor of Biological Sciences, Professor, Head of the SibMed Laboratory of Genetic Technologies, Leading Oncoimmunologist at the Institute of Transfusion Medicine and Immunology, Medical Faculty Mannheim, University of Heidelberg.
Languages: Russian, English.
Date: December 15–16, 2021.